Because a combination of CD4 and CD8 responses is required for sustained memory and antitumour activity (Pardoll and Topalian, 1998), a panel of T-cell clones is probably needed to address the genetic and antigenic heterogeneity of tumour cells (Loeb, 2001). This evidence concerns the gene CD8A and neoplasm.